雪旺氏细胞内NGF含量的定量测定方法研究

目的：建立一套测定单个细胞内蛋白含量的新方法。方法：纯化培养乳鼠雪旺氏细胞，施加实验因素，通过间接免疫荧光法标记细胞内ＮＧＦ蛋白，而后用流式细胞仪（适用于细胞悬液样品）或粘附细胞仪（适用于粘附细胞样品）进行测定。结果：流式细胞仪及粘附细胞仪均可得到每一实验组的精确测定结果，并能进行统计分析，提供统计图表和各种数据。结论：应用流式细胞仪或粘附细胞仪可对单个雪旺氏细胞内的ＮＧＦ含量进行定量研究     

Effect of adenosine and β-endorphin on contractions of the vas deferens of rats differing in predisposition to ethanol

Laboratory for the Search for and Study of Agents for Prevention and Treatment of Drug Addictions, Research Institute of Pharmacology, Academy of Medical Sciences of the USSR, Moscow. (Presented by Academician of the Academy of Medical Sciences of the USSR A. V. Val'dman.) Translated from Byulleten' Éksperimental'noi Biologii i Meditsiny, Vol. 108, No. 12, pp. 700–702, December, 1989.     

Effect of thymosin and B-activin on lateralization of sensomotor control in rats

Research Institute of General Pathology and Pathological Physiology, Academy of Medical Sciences of the USSR Research Laboratory of Biologically Active Substances of Hydrobionts, Ministry of Health of the USSR, Moscow. (Presented by Academician of the Academy of Medical Sciences of the USSR G. N. Kryzhanovskii.) Translated from Byulleten' Éksperimental'noi Biologii i Meditsiny, Vol. 108, No. 8, pp. 139–142, August, 1989.     

内皮细胞微丝结构与血管内皮完整性关系的探讨

为证实内皮细胞微丝与血管内皮完整性之间的直接关系，用Ｒｈｏｄａｍｉｎｅ－ｐｈａｌｌｏｉｄｉｎ显示了体外培养的牛主动脉内皮细胞形成一微密单层细胞后的微丝形态及用细胞毒素Ｂ孵育单层内皮细胞后的细胞形态及微丝的变化。结果表明：内皮细胞内的微丝结构ＤＰＢ是维持内皮细胞之间连接的重要结构。文内还对内皮细胞微丝结构与动脉粥样硬化早期病变的关系进行了讨论。     

妊高征患者淋巴细胞β_2－肾上腺素能受体结合量改变及与新生儿体重关系的研究

应用放射配体结合分析，测定４０例正常晚期妊娠妇女及４０例妊高征妇女外周血淋巴细胞β_２－肾上腺素能受体（β_２－ＡＲ）结合量，并测定两组妇女分娩的新生儿体重。结果为：１．正常晚期妊娠妇女外周淋巴细胞β_２－ＡＲ结合量明显降低，妊高征妇女β_２－ＡＲ结合量降低更显著；２．妊高征孕妇组的新生儿出生体重明显低于正常妊娠组的新生儿体重；３．孕妇β_２－ＡＲ结合量与新生儿出生体重呈明显正相关，提示好高征与机体β_２－ＡＲ结合量下降有关，β_２－ＡＲ改变影响胎儿生长发育。     

白内障晶状体上皮细胞及晶状体纤维超微结构的观察

应用胎儿晶状体发育的超微结构为形态学依据,观察老年性、外伤性、先天性白内障晶状体的超微结构.结果:老年性白内障晶状体上皮多数细胞膜破裂,作者首先发现其原因是相邻细胞顶部的紧密连结缺失,房水侵入所致.胞质中线粒体空泡化,内质网扩张、脱粒.晶状体纤维膨胀、崩溃.细胞之间的各种连结消失.外伤性白内障除具有白内障特点外,胞质中出现大量溶酶体、残体.1例先天性白内障,上皮细胞发育尚好,晶体纤维不发育.     

Diverse locations of amino acids in HLA-DR beta chains involved in polymorphic antibody binding epitopes on DR(alpha, beta 1*0101), DR(alpha, beta 1*1101), and DR(alpha,beta 3*0202) molecules.

In a previous study, we used transfectants expressing hybrid HLA-DR(beta 1*0403)/DR(beta 1*0701) chains to map sequences involved in polymorphic antibody binding epitopes on DR(alpha, beta 1*0403) or DR(alpha, beta 1*0701) molecules. Amino acids 1-40 of the beta 1 domain were found to make the major contributions to most of the antibody binding epitopes studied. To begin to localize sequences that contribute to polymorphic antibody epitopes on DR(alpha,beta 1*0101), DR(alpha,beta 1*1101) and DR(alpha,beta 3*0202) molecules, we used indirect immunofluorescence and flow cytometry to assess the binding of mAb to transfectants expressing hybrid DR(beta 1*0101)/DR(beta 1*1101) or DR(beta 1*1101)/DR(beta 3*0202) chains that divide the DR beta chain into three segments: amino acids 1-40, 41-97, and the beta 2 domain. The results indicate that amino acids 41-97 of the beta 1 domain on DR(beta 1*0101), DR(beta 1*1101), or DR(beta 3*0202) are critical in most of the epitopes, including those recognized by human antibodies MP4 and MP12, and mouse mAb GS88.2, I-LR1, 21r5, and 7.3.19.1, whereas amino acids 1-40 of DR(beta 1*1101) are critical in the epitope recognized by the MCS-7 mAb, and both segments 1-40 and 41-97 of DR(beta 1*1101) are important in the epitopes recognized by the I-LR2 and UL-52 mAbs. Based on these data and comparison of DR beta allelic protein sequences, the residues that may play critical roles in these antibody binding epitopes are predicted.